Novo Integrated Sciences Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Novo Integrated Sciences Inc (NVOS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Novo Integrated Sciences Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 13M vs 215,687M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+43.7% annualized vs trailing 12 months), vs decelerating (-19.1%) for its tracked peer group.
- Growth: Novo Integrated Sciences Inc generated 38.6% revenue growth year over year in Q4 2024, vs -0.8% for its tracked competitors combined.
- Profitability: Its 109.5% net margin compares with 13.2% for the peer group.
- Peer revenue share: Novo Integrated Sciences Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.41M compares with $0.67M for the peer group (0.6x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
NVOS Sales vs. its Competitors, Q4 2024
Novo Integrated Sciences Inc reported revenue growth of 38.57 % year on year in Q4 2024, above its competitors' combined revenue change of -0.84 %.
With a net margin of 109.54 %, Novo Integrated Sciences Inc achieved higher profitability than its competitors (13.16 %).
Novo Integrated Sciences Inc generated 0.01 % of the combined sales of its peer group, up from 0.01 % a year earlier.
Novo Integrated Sciences Inc vs. its Competitors, Q4 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Novo Integrated Sciences Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Novo Integrated Sciences Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (4) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Novo Integrated Sciences Inc's competitor groups requires a Commercial License.
For context: the Auto & Truck Parts industry grew revenue 4.6% year over year, combined, vs 38.6% for Novo Integrated Sciences Inc. Novo Integrated Sciences Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Novo Integrated Sciences Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Novo Integrated Sciences Inc | No | Yes | Yes | No |
| Competitors combined (16) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 8) | 75.00 % (6 of 8) | 50.00 % (4 of 8) | 28.60 % (2 of 7) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
NVOS Stock Performance relative to its Competitors
NVOS Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Diversified Healthcare Trust | 282.9% | Outperformed |
| 2 | Caterpillar Inc | 282.9% | Outperformed |
| 3 | Borgwarner Inc | 282.9% | Outperformed |
| 4 | Enpro Inc | 282.9% | Outperformed |
| 5 | Woodward Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Novo Integrated Sciences Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Novo Integrated Sciences Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Novo Integrated Sciences Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Novo Integrated Sciences Inc | 0.07 | 12.74 |
| Caterpillar Inc | 379,226.88 | 74,729.00 |
| General Electric Company | 333,197.28 | 50,638.00 |
| Honda Motor Co Ltd | 151,773.25 | 142,458.01 |
| Cummins Inc | 71,720.84 | 34,708.00 |
| Barrick Mining Corp | 70,140.63 | 16,956.00 |
| SUBTOTAL | 1,076,088.10 | 358,158.21 |
Sign in to see all competitors of Novo Integrated Sciences Inc .
Sources: Novo Integrated Sciences Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Novo Integrated Sciences Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Novo Integrated Sciences Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Diversified Healthcare Trust | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Novo Integrated Sciences Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Novo Integrated Sciences Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Novo Integrated Sciences Inc | Health Care Services 65.12 % |
| Caterpillar Inc | Construction Industries 41.12 % |
| General Electric Company | Commercial Engines and Services, Reportable 72.90 % |
| Cummins Inc | Distribution 35.17 % |
| Borgwarner Inc | Turbos & Thermal Technologies 40.56 % |
| Generac Holdings Inc | Residential Segment 52.81 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Novo Integrated Sciences Inc .
Novo Integrated Sciences Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Novo Integrated Sciences Inc | 0 | 411,049 | -520,276 |
| Caterpillar Inc | 379,227 | 633,297 | 91,873 |
| General Electric Company | 333,197 | 888,386 | 157,579 |
| Honda Motor Co Ltd | 151,773 | 730,580 | 30,418 |
| Cummins Inc | 71,721 | 514,955 | 41,944 |
| Barrick Mining Corp | 70,141 | 2,608,615 | 1,100,615 |
| PEERS TOTAL | 1,076,088 | 674,856 | 71,820 |
Sign in to see all peers for Novo Integrated Sciences Inc .
Novo Integrated Sciences Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Caterpillar Inc | Latin America -0.11 % |
| Cummins Inc | United States 56.10 % |
| Borgwarner Inc | Europe 37.96 % |
| Enpro Inc | United States 56.79 % |
| Brunswick Corporation | United States 64.92 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Novo Integrated Sciences Inc .
Novo Integrated Sciences Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 52 companies in Novo Integrated Sciences Inc's industry classification, broader than the peer set above. Market cap in millions of $.Novo Integrated Sciences Inc ranks #0 of 52 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,190, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Cummins Inc | 72,399 | 30.24 % |
| 2 | Magna International Inc | 18,337 | 7.66 % |
| 3 | Genuine Parts Co | 17,713 | 7.40 % |
| 4 | Borgwarner Inc | 12,741 | 5.32 % |
| 5 | Bwx Technologies Inc | 1,234 | 5.2% |
| 6 | Modine Manufacturing Co | 1,234 | 5.2% |
| 7 | Allison Transmission Holdings Inc | 1,234 | 5.2% |
| 8 | Aptiv Plc | 1,234 | 5.2% |
| 9 | Autoliv Inc | 1,234 | 5.2% |
| 10 | Lear Corp | 1,234 | 5.2% |
| 0 | Novo Integrated Sciences Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Novo Integrated Sciences Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-25.
Novo Integrated Sciences Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Auto & Truck Parts industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (79 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 45.07 % | 22.21 % (avg) | +22.9 pp |
| Operating Margin | -79.08 % | industry median | -83.1 pp |
| EBITDA Margin | -55.12 % | -1.10 % (avg) | -54.0 pp |
| Capital Intensity (Capex / Revenue) | 0.00 % | 6.94 % (avg) | -6.9 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Novo Integrated Sciences Inc's Valuation vs Competitive Position
Valuation multiples vs the Auto & Truck Parts industry average (79 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 22.2x | - |
| EV / EBITDA | - | 13.9x | - |
| P/B | 0.0x | 2.6x | -2.6x |
| Return on Equity | -92.52 % | industry aggregate | -107.37 % |
| Return on Invested Capital | -26.80 % | 1.99 % (avg) | -28.79 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Novo Integrated Sciences Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2015 | 2017 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue Growth | - | - | 7.89 % | -22.69 % | -0.89 % | 3.06 % |
| Operating Margin | - | - | -6.70 % | -66.20 % | -224.03 % | 129.23 % |
| Return on Invested Capital | - | - | -1.22 % | -7.83 % | -30.43 % | 25.48 % |
| P/E | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Novo Integrated Sciences Inc's Strategic Group Map
Every company in Novo Integrated Sciences Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Novo Integrated Sciences Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Novo Integrated Sciences Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,190 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.00 % vs industry average 6.94 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Novo Integrated Sciences Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Novo Integrated Sciences Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Novo Integrated Sciences Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Novo Integrated Sciences Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Novo Integrated Sciences Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+43.7% annualized vs trailing 12 months).
Weaknesses
- Operating margin 83.1 points below the industry median.
- Return on equity 107.4 points below the industry aggregate.
Opportunities
- A meaningful share of tracked competitors (37.50 %) show financial-distress signals, a possible opening to gain share.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-19.1% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Novo Integrated Sciences Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Novo Integrated Sciences Inc | 0.08 | 0.40 | 0.11 |
| Caterpillar Inc | 0.19 | 1.39 | 0.99 |
| General Electric Company | - | 0.86 | 1.09 |
| Honda Motor Co Ltd | 0.53 | 1.36 | 0.76 |
| Cummins Inc | 0.19 | 1.76 | 0.64 |
| Barrick Mining Corp | 1.92 | 2.92 | 0.18 |
Sign in to see all peers for Novo Integrated Sciences Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Novo Integrated Sciences Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Novo Integrated Sciences Inc | Q3 2024 | +38.6 % | - |
| Caterpillar Inc | Q2 2026 | +24.0 % | +64.9 % |
| General Electric Company | Q2 2026 | +21.1 % | +16.6 % |
| Honda Motor Co Ltd | Q1 2024 | +1.9 % | -26.7 % |
| Cummins Inc | Q2 2026 | +9.4 % | +4.3 % |
| Barrick Mining Corp | Q4 2025 | +48.8 % | +266.3 % |
| PEERS TOTAL | +8.5 % | +31.6 % |
Sign in to see all peers for Novo Integrated Sciences Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Novo Integrated Sciences Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Novo Integrated Sciences Inc | Q3 2024 | +26.3 % | -90.0 % |
| Caterpillar Inc | Q2 2026 | +18.3 % | +16.3 % |
| General Electric Company | Q2 2026 | +540.9 % | +2.4 % |
| Honda Motor Co Ltd | Q1 2024 | +4.5 % | +40.7 % |
| Cummins Inc | Q2 2026 | +9.9 % | +7.8 % |
| Barrick Mining Corp | Q4 2025 | +4.2 % | +23.8 % |
Sign in to see all peers for Novo Integrated Sciences Inc .
Novo Integrated Sciences Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Novo Integrated Sciences Inc | - | - | - |
| Caterpillar Inc | 11.11% | 17.90% | 54.18% |
| General Electric Company | 6.98% | 11.25% | 48.50% |
| Honda Motor Co Ltd | 2.89% | 4.01% | 7.04% |
| Cummins Inc | 8.21% | 10.31% | 21.02% |
| Barrick Mining Corp | 13.87% | 15.24% | 19.92% |
Sign in to see all peers for Novo Integrated Sciences Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Novo Integrated Sciences Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Novo Integrated Sciences Inc | - | 0.01 |
| Caterpillar Inc | 35.33 | 5.07 |
| General Electric Company | 37.57 | 6.58 |
| Honda Motor Co Ltd | 27.53 | 1.07 |
| Cummins Inc | 26.45 | 2.07 |
| Barrick Mining Corp | 14.02 | 4.14 |
| PEERS AVERAGE | 28.24 | 3.00 |
Sign in to see all peers for Novo Integrated Sciences Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.